-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Reinstates Buy on Ligand Pharmaceuticals, Announces $387 Price Target

Benzinga·07/21/2026 19:00:30
Listen to the news
Citigroup analyst Yigal Nochomovitz reinstates Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and announces $387 price target.